Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxygen Supplementation During Sit-To-Stand Test in COPD
NCT07024914Active, not recruiting
- Sponsor
- G. Papanikolaou General Hospital
- Start
- Sep 2019
- Primary completion
- Dec 2025
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Randomised, single-blind trial of oxygen in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by G. Papanikolaou General Hospital. Primary endpoint: Cerebral oxygenation at the prefrontal lobe at 2.5 minutes. Started Sep 2019; status: active, not recruiting.
02
Drugs
oxygen
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07024914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07024914.